AAO: Genentech provides update on presentations, product portfolio

Video

Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.


Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of some of the company’s podium presentations from the Port Delivery System with ranibizumab to the novel pipeline molecule, faricimab.

Recent Videos
3 experts are featured in this series.
2 experts in this video
3 experts are featured in this series.
2 experts in this video
2 experts in this video
2 experts in this video
3 experts are featured in this series.
3 experts are featured in this series.
2 experts in this video
2 experts in this video
Related Content
© 2025 MJH Life Sciences

All rights reserved.